Five states enacted significant healthcare legislation during spring 2026 sessions. Arizona launched AI-powered Medicaid fraud detection, while Iowa banned insurers from using AI to deny prior authorizations under HF 2635. Missouri's comprehensive HB 2372 awaits gubernatorial approval, expanding Medicaid coverage and hospital transparency requirements. Maryland's Prescription Drug Affordability Board capped Ozempic payments at Medicare rates for state plans. Connecticut's budget bill (SB 1) overhauled Certificate of Need requirements for hospitals.

Attorneys general are expanding their influence over health policy through opioid settlements, PBM reform, and Medicaid oversight. The Purdue/Sackler settlement yielded $7.4 billion effective May 1. Bipartisan coalitions of 39 and 45 attorneys general advocated for PBM reforms. Republican attorneys general challenged FDA mifepristone regulations, with Louisiana's litigation prompting Fifth Circuit action. Texas and Florida launched Medicaid fraud investigations and task forces.

No state Medicaid program provides broad IVF coverage, though New York, Utah, and Washington, D.C. offer limited fertility benefits. Utah implemented IVF coverage in 2024 for carriers of specific genetic diseases, while New York and D.C. cover three cycles of ovulation-enhancing drugs. Seven states require Medicaid fertility preservation coverage for iatrogenic infertility. Private insurance mandates have expanded significantly, with 15 states now requiring IVF coverage and 21 states mandating fertility preservation coverage.

Nebraska became the first state to implement Medicaid work requirements on May 1, 2026. North Dakota's 340B pharmacy law was ruled unconstitutional, the second such ruling favoring drug manufacturers. Tennessee enacted legislation allowing Ballad Health's Certificate of Public Advantage to expire in June 2028 despite FTC warnings. Virginia legislators unanimously rejected Governor Spanberger's amendments delaying Medicare Maximum Fair Price controls.

The U.S. Supreme Court will decide by May 14, 2026, whether to reinstate mifepristone's in-person dispensing requirement nationwide, potentially reversing the FDA's 2023 change allowing telehealth prescriptions and mail distribution. Louisiana's lawsuit challenges this change, with courts finding the state likely has standing. Republican attorneys general from multiple states have filed cases targeting the FDA and out-of-state abortion medication providers, intensifying conflicts with Democratic states' shield laws.

State Medicaid programs face severe fiscal constraints, with at least 14 states experiencing shortfalls last fiscal year. During 2026 legislative sessions, states implemented cost-containment measures: Colorado capped enrollment at 25,000 for its immigrant coverage program; Idaho cut reimbursement rates by $21.8 million; Iowa addressed a $91 million shortfall through increased MCO taxes; North Carolina raised copayments and tightened eligibility; Oklahoma debates expansion authority while adding $250 million in funding.

Only 13 state Medicaid programs cover GLP-1 medications for weight loss as of early 2026, down from 17 states before January 1. California, New Hampshire, Pennsylvania, and South Carolina dropped coverage citing budgetary constraints. The 13 remaining states impose strict restrictions including BMI thresholds over 30, prior authorization, and step therapy requirements. CMS introduced the BALANCE demonstration program allowing states to expand coverage through negotiated pricing beginning May 2026.

Oklahoma's House approved two measures for an August 25, 2026 special election ballot that would allow lawmakers to modify or end the state's voter-approved Medicaid expansion. One proposal (HB 4440) would move expansion from the constitution to statute; another (HJR 1067) would end expansion if federal funding drops below 90 percent. Similar efforts are underway in South Dakota and Missouri.

Twenty-five states and Washington, D.C. currently require private insurance coverage for fertility care, while only New York, Utah, and D.C. offer limited Medicaid coverage. In 2026, Virginia enrolled legislation requiring coverage for three IVF cycles by 2028, while Arizona and Hawaii advanced bills mandating coverage for iatrogenic infertility. Connecticut expanded its infertility definition under existing mandates, reflecting states' focus on incremental coverage expansions.

States are advancing healthcare legislation across three key areas as legislative sessions conclude. Multiple states enacted insurance reforms targeting utilization management and prior authorization, with Iowa, Utah, South Dakota, Washington, and New Mexico leading efforts. Indiana, Wyoming, and Utah passed Medicaid eligibility verification measures responding to federal reforms. Several states expanded scope of practice for pharmacists and mid-level providers to qualify for Rural Health Transformation Program funding.

Healthcare policy groups including FARB, NAIC, NAMD, NASHP, and NCOIL serve as platforms for state policymakers to collaborate and shape emerging trends. In 2025, multiple organizations adopted model legislation on facility fees and site-neutral payments, with NCOIL passing its Prior Authorization Reform Model Act in November. Groups are now focusing on the Rural Health Transformation Program and 340B oversight for 2026.

Florida's Senate Committee on Health Policy voted 6-4 on January 29th to advance SB 1756, the Medical Freedom Act, which prohibits the State Health Officer from ordering vaccinations and establishes conscience protections as exemptions from school-entry vaccine requirements. The bill requires providers to obtain signed informed consent before administering vaccines to minors and awaits consideration in the Appropriations Committee.

Republican governors in Texas, Indiana, and Oklahoma are strengthening Medicaid oversight to combat fraud and abuse. Texas Governor Abbott directed reviews of high-risk services including autism care and enhanced managed care investigations. Indiana’s EO 26-04 established a Council on Fraud Detection and Prevention coordinating state agencies. Oklahoma’s EO 2026-02 mandates comprehensive welfare program reviews covering Medicaid, SNAP, and WIC, including fraud protocols and eligibility requirements.

Following September 2025 federal restrictions limiting COVID-19 vaccine eligibility to adults 65+ and high-risk individuals, 18 states implemented protective measures including executive orders allowing pharmacy administration without prescriptions. Regional alliances like the West Coast Health Alliance and Northeast Public Health Collaborative emerged, while Florida moved to eliminate school vaccine mandates. The bipartisan Governor's Public Health Alliance launched October 15 with 15 governors coordinating responses.

Delaware legislators introduced SB 213 eliminating hospital budget oversight authority, while Florida faces court-ordered Medicaid termination pauses after constitutional violations. North Carolina's certificate of need laws face ongoing legal challenges, and New York Governor Hochul proposed $71 million in healthcare investments including mental health licensing reforms. Utah became the first state implementing AI prescription renewals for chronic conditions.

Fifteen governors launched a public health alliance to improve emergency preparedness and coordination across state lines, while CMS announced all 50 states applied for the $50 billion Rural Health Transformation Program. California enacted major healthcare transparency and PBM oversight legislation, Colorado proposed significant Medicaid spending cuts, and Massachusetts advanced prior authorization reforms.

The National Council of Insurance Legislators adopted the Prior Authorization Reform Model Act and advanced artificial intelligence oversight policies at its Atlanta annual meeting. The Health Insurance Committee addressed charity care screening requirements and medical debt protections, while the Financial Services Committee continued developing AI governance standards requiring human professionals to make claim denial decisions. Legislators discussed expiring ACA tax credits' impact on market stability with state insurance commissioners.

Seventeen state Medicaid programs now cover rapid whole genome sequencing for critically ill children, with Minnesota, North Carolina, Oklahoma, and Tennessee extending coverage to patients under 21 in pediatric critical care. Sixteen states mandate biomarker testing coverage for cancer-risk beneficiaries. Maryland and Illinois enacted legislation prohibiting genetic discrimination in life insurance policies.

CMS released guidance for states applying to the Rural Health Transformation Program's $50 billion in federal funding distributed between FY2026-FY2030. States like Mississippi, Oklahoma, North Dakota, and Washington are conducting stakeholder surveys and forming committees to develop applications focusing on workforce development, technology infrastructure, and healthcare access improvements. Applications are due November 5, 2025, with approvals by December 31.

President Trump signed the One Big Beautiful Bill Act on July 4, 2025, cutting federal Medicaid spending by $1.02 trillion over ten years. The legislation imposes work requirements, freezes provider tax rates, caps state-directed payments, and requires six-month eligibility redeterminations for expansion states. Most significant budget impacts won't hit states until 2028.